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Purpose: The present study was concerned with the development of a new experimental model of dry eye using human
reconstructed in vitro corneal epithelium (HCE). The model is based on the use of adapted culture conditions that induce
relevant modifications at the cellular and molecular level thus mimicking dry eye.
Methods: The HCE model was maintained in a controlled environmental setting (relative humidity <40% and 40 °C
temperature) for 24 h and up to 72 h to induce dry eye. The evolution of the dry eye condition was assessed by histology,
immunohistochemistry  staining,  scanning  electron  microscopy,  and  gene  expression  by  using  TaqMan  gene  assay
technology (mucin-4 [MUC4], matrix metallopeptidase-9 [MMP9], tumor necrosis factor-α [TNF-α], and defensin β-2
[DEFB2). The effects of different commercially available tear substitutes on the induced dry eye condition were tested.
Results: This in vitro dry eye HCE model, that was well established within 24 h, has the characteristic features of a dry
eye epithelium and could be satisfactorily used for preliminary assessment of the protective activity of some artificial
tears. The transcriptional study of selected biomarkers showed an increase in MUC4, MMP9, TNF-α, and hBD-2
(DEFB2) gene expression.
Conclusions: By using a dynamic approach, we were able to define a biomarker gene signature of dry eye-induced effects
that could be predictive of corneal damage in vivo and to discriminate the efficacy among different commercial artificial
tears.
Dysfunctional tear syndrome (DTS) or dry eye disease is
a multifactorial disease of the tears and ocular surface that
results in symptoms of discomfort, modification of the tear
film  composition,  and  tear  film  instability,  with  potential
damage to the ocular surface [1]. The precorneal tear film has
a three-layer structure: a mucous layer in contact with the
ocular surface, an intermediate aqueous layer, and an anterior
lipid layer. The aqueous layer is involved in lubrication and
protection of the ocular surface and contains soluble mucin
and  microvilli.  Mucins  are  large,  highly  glycosylated
glycoproteins that are major components of the mucus layer
adjacent to ocular surface epithelia. They play a key role in
retention of water and other tear fluid components on the
surface of the apical cell, thus preventing desiccation of the
epithelial surface [2]. Mucins also lubricate the ocular surface
during the eyelid blink, help to maintain a smooth refractive
surface, and provide a barrier to pathogen penetration. The
epithelial cells contribute to secretion of tear mucus and the
microvilli of the apical epithelial cells increase the surface for
tear  adherence.  The  protective  function  of  the  microvilli
(which change in amount and structure) is closely related to
tear film stability [3]. In dry eye, dysfunction of the ocular
surface-secretory  glandular  functional  unit  can  lead  to  an
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epithelial disease, termed keratoconjunctivitis sicca (KCS)
[1]. Dry eye symptoms range from mild, transient irritation to
persistent dryness, burning, itchiness, redness, pain, ocular
fatigue, and visual disturbance. Dry eye disease is associated
with a decrease in aqueous tear production, abnormalities of
the lipid, protein, and mucin profiles [4], and an increased
osmolarity and inflammation of the ocular surface. Increased
concentrations  of  proinflammatory  cytokines  have  been
implicated in dry eye syndrome, which occur either on the
ocular surface or in the lacrimal gland. Reduced levels of
growth factor and soluble mucin, and the presence of activated
proteases  (such  as  matrix  metallopeptidase  [MMP9]  that
degreade  the  extracellular  matrix)  along  with  the  tight
junction protein occludin are also observed [5-8].
Several different animal models of dry eye have been
proposed, including surgical removal of the tear-producing
glands, ocular surface desiccation by mechanical inhibition of
blinking, and pharmacologic inhibition of tear secretion [9].
However, these models are labor-intensive and difficult to
manage for prolonged periods. All existing animal models of
dry eye mimic different pathogenic mechanisms of KCS, but
none  appear  to  mirror  precisely  the  molecular  and
morphological modification characteristic of a DTS. A dry
eye non-animal model that mimics human dry eye disease
would be a useful tool to investigate the multiple factors
implicated in the pathogenesis of KCS.
The corneal epithelium, a non-keratinized multilayered
squamous epithelium of about 60 μm, plays a crucial role in
Molecular Vision 2011; 17:113-126 <http://www.molvis.org/molvis/v17/a15>
Received 6 August 2010 | Accepted 5 January 2011 | Published 12 January 2011
© 2011 Molecular Vision
113the barrier function and can be considered the first line of
defense against many types of injury, trauma, or infection.
Furthermore, the corneal epithelium is directly involved in the
establishment  of  dry  eye  and  the  discomfort  and  pain
associated with dry eye syndrome. In vitro, 3D models of
human corneal epithelium have been developed during the last
ten years [10]. These models are versatile for the set-up of
modified  protocols  and  allow  objective  and  reproducible
quantification of complementary testing parameters [11-14].
Compared  to  in  vivo  studies  on  animals  and  cell  culture
models,  the  in  vitro  tissue  is  an  easy-to-handle  model  of
human origin that more closely resembles human epithelial
physiology  than  conventional  monolayer  models.  In  vitro
tissue has increased permeability compared to in vivo tissue
[15,16];  however,  this  could  be  considered  as  a  further
advantage for the design of sensitive experimental models that
allow early detection of the effects of sub-toxic doses.
The purpose of this study was to establish experimentally
induced  dry  eye  in  vitro  (EDEV)  on  a  human  corneal
epithelium (HCE) model. Culture conditions were modified
to  induce  the  most  relevant  morphological,  cellular,  and
molecular modifications related to dry eye symptoms, namely
inflammation  and  modification  of  the  structural
compartments of the ocular surface and microvilli ‘network’.
By  using  positive  and  negative  HCE  controls  in  our
experimental model, various parameters likely to be modified
by  specific  culture  conditions  were  investigated.  Cellular
viability was assessed by the Alamar Blue test, epithelium
morphology  was  examined  by  light  microscopy,  and  the
structure of epithelial surface microvilli assessed by scanning
electron  microscopy  (SEM).  Transcriptional  analysis  of  a
selected gene signature was performed via real-time reverse
transcription  polymerase  chain  reaction  (qRT–PCR).  The
genes analyzed included MMP9 (matrix metallopeptidase-9)
and  TNFα  (tumor  necrosis  factor-α,  an  inflammatory
mediator), as increased expression of both has been observed
in ocular surface epithelial diseases and in the tear fluid of
patients with dry eye [17-19]. Mucin-4 (MUC-4) expression
was  analyzed  due  to  its  known  lubricating  and  clearing
function  and  its  role  as  a  surface-associated  mucin  in
providing  barrier  function  to  corneal  and  conjunctival
epithelia  [20,21].  Expression  of  human  defensin  β-2
(DEFB2)  was  evaluated  due  its  role  in  antimicrobial
protection and in ocular surface damage in subjects with dry
eye [22,23]. After optimizing experimental conditions for the
induction of a dry and inflamed epithelium (Part 1), different
commercially  available  formulations  called  artificial  tears
were  assessed  (Part  2).  They  do  not  have  a  direct
pharmacological activity but containing polymers of various
origin (biotechnology and natural derived or synthetic) they
are able to directly interact with the ocular surface and in
particular with the corneal epithelium. In vivo they can show
a lubrificating action by reducing friction between lids and
cornea surface. Because of the peculiar chemical physical
characteristics of the polymer, when applied at the surface of
the 3D HCE model, these tear substitutes interact with the
epithelium structure at molecular level giving the interesting
opportunity  to  modeling  the  corneal  epithelium  response
during  the  molecular  and  morphological  modifications
induced by the dry condition. Any lubrificating or hydrating
efficacy  should  be  applied  to  the  different  mechanism
observed.
METHODS
Biologic model: The reconstructed HCE model was supplied
by  SkinEthic®  Laboratories  (Nice,  France).  The  model
consisted  of  immortalized  human  corneal  epithelial  cells
(IHCEC) cultured on an inert, permeable polycarbonate filter
of  0.5  cm2  for  5  days  at  the  air-liquid  interface  in  a
supplemented chemically defined medium (modified MCDB
153). The overall morphology of the HCE model was similar
to  that  of  human  corneal  epithelium,  with  a  flattened
superficial layer of non-keratinized cells. At the intermediate
cell  layer  the  cells  displayed  more  lateral  cytoplasmatic
extensions than those in the basal layer, similar to the wing
cells. The basal layer consisted of regular column cells. At the
ultrastructural  level,  the  basal  membrane  revealed  mature
hemidesmosomes  and  associated  anchoring  filaments  that
form the complex for attachment of the epithelium to the
stroma  in  vivo.  The  resulting  3D  construct  showed  the
morphology of the stratified cellular organization of HCE
which has previously been characterized for different relevant
markers [11]. HCE tissues were shipped on day 5: upon arrival
they were aseptically removed and placed in a 6-well culture
plate (Falcon; VWR, Milan, Italy) with 1 ml of chemically-
defined maintenance medium supplied by SkinEthic (changed
every 24 h). Different batches of HCE were used, with an
average thickness of 70 μm (as reported in the quality data
sheet for each batch). For each product and assay 2 HCE have
been used.
PART 1: Experimentally induced in vitro dry eye on HCE
model (EDEV): HCE tissues were placed under controlled
environmental conditions to mimic dryness (<40% relative
humidity, 40 °C±5 °C temperature and 5% CO2). Tissues were
investigated for different parameters (cell viability, histology,
and mRNA expression of selected genes) at 24 h, 48 h, and
72 h after establishment of dry eye conditions. These tissues
are coded as EDEV-HCE.
AlamarBlue  assay—AlamarBlue  (Sigma-Aldrich,
Milan,  Italy)  is  a  redox  indicator  dye  that  produces  a
colorimetric  change  in  response  to  metabolic  activity.  In
viable cells AlamarBlue is reduced by cytochromes, NADPH,
NADH, FADH, and FMNH. Unlike other markers (e.g., MTT
and Trypan Blue) AlamarBlue does not interfere with cell
viability. The absorption spectra of AlamarBlue changes from
the  oxidized  form  (blue)  to  the  reduced  form  (red).  10%
AlamarBlue was added directly to the medium of the tissue
models cultivated in standard or controlled EDEV conditions
Molecular Vision 2011; 17:113-126 <http://www.molvis.org/molvis/v17/a15> © 2011 Molecular Vision
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spectra was determined by measuring the absorbance at 570
and  600  nm.  The  percentage  of  reduced  AlamarBlue
represented the quantity of viable cells.
At specific time points (24 h, 48 h, and 72 h), the %
reduction  (survival  rate)  of  AlamarBlue  was  calculated
relative to non-treated tissues using the following formula
(Alamar Assay Booklet from Biosource):
% reduction =
(εox)λ2 * Aλ1 − (εox)l1 * Aλ2 treated sample (EDEV)
(εox)l2 * A ° λ1 − (εox)l1 * A ° λ2 non treated tissue (positive control) *100
where λ1=570 nm and λ2=600 nm.
(εox)λ1=80,586  (molar  extinction  coefficient  of
Alamar Blue (oxidised) at wavelength 570 nm)
(εox)λ2=117,216  molar  extinction  coefficient  of
Alamar Blue (oxidised) at wave lenght 600 nm)
Aλ1=absorption of the sample at 570 nm
Aλ2=absorption of the sample at 600 nm
A°λ1=absorption of the positive control at 570 nm
A°λ2=absorption of the positive control at 600 nm
Histology—At the end of an experiment, a single HCE
tissue was removed from the insert using a sharp scalpel and
fixed in 10% formalin solution (HT501128). After embedding
in paraffin, vertical sections (4 μm thick) were cut with a
microtome  and  hematoxylin  and  eosin  (H&E)  stained
following  internal  procedures.  Histological  samples  were
analyzed under a light microscope and the overall morphology
of the epithelium and its modifications compared to untreated
negative HCE controls.
Immunofluorescence—Vertical  sections  of  frozen
epithelium (7 µm thick) were cut with a cryotome (Leica CM
3050, Leica Microsystems AG, Wetzlar, Germany) and stored
at  –80  °C  until  staining.  Sections  were  subjected  to
immunofluorescence  with  antibodies  against  MMP9  and
MUC4. Sections were rinsed with 1% BSA-PBS and two
different sets of primary antibodies added in 1% BSA-PBS:
the  mouse  monoclonal  anti-MMP9  clone  GE-213  (1:800;
Santa Cruz Biotechnology; DBA Italia, Segrate(MI), Italy)
and the rabbit polyclonal anti-mucin 4 (1:50, Santa Cruz). A
biotine/streptavidin detection system was used to amplify the
signal. Biotinylated secondary antibodies bind to the primary
antibody.  FITC-streptavidin  is  then  applied.  After  three
washes in PBS the nuclei were labeled with propidium iodide
and mounted in an anti-fade medium (Vectashield; Vector
Laboratories; DBA Italia, Segrate(MI), Italy). Samples were
viewed under a fluorescence microscope (Leica DMLB; Leica
Microsystem, Wetzler, Germany, with a CCD Sony DXC
390P;).
Evaluation of microvilli and mucins with scanning
electron  microscopy—HCE  Samples  were  fixed  in  2.5%
glutaraldehyde in 0.1 M phosphate buffer for 2 h at 4 °C.
Slides were washed three times for 5 min in 0.1M phosphate
buffer and then placed in 1% OsO4 in 0.1 M phosphate buffer.
Samples were dehydrated through a graded series of ethanol
and  critical-point-dried  in  a  CO2  liquid  Bemar  SPC  1500
(Bomar  Co,  Tacoma,  WA)  apparatus.  Specimens  were
mounted on aluminum stubs with silver-conducting paint,
sputtered with a thin (20 nm) film of gold, and observed with
a ESEM QUANTA 200 (FEI, Eindhoven, The Netherlands).
Transcriptional  study  of  mRNA  (qRT–PCR)—At
each treatment time point, total RNA was extracted from HCE
using the RNAqueous kit according to the manufacturer’s
protocol (Ambion-Applied Biosystems, Monza, Italy). The
cDNAs were then synthesized using 2 µg of RNA template in
a  20  µl  reaction  using  the  High-Capacity  cDNA  Reverse
Transcription  Kit  (Ambion-Applied  Biosystems).  RNA
(10 µl) was added to the master mix, which was subjected to
reverse transcription in a thermal cycler (ABI PRISM 7500
Real Time PCR System; Ambion-Applied Biosystems) under
the following conditions: 25 °C for 10 min, 37 °C for 60 min,
85 °C for 5 s. Real Time Polymerase Chain Reaction was
subsequently performed in triplicate in a 25 µl final reaction
volume using the Applied Biosystems ABI PRISM 7500 Real
Time PCR System instrument with TaqMan® assay (Ambion-
Applied  Biosystems).  The  cDNA  was  amplified  using
TaqMan  Universal  PCR  Master  Mix  and  TaqMan  gene
expression  assay  provided  as  a  20×  Assay  mix  (Human
MMP9:  TaqMan  probe  MMP9  Hs00234579_m1;  Human
TNFα:  TaqMan  probe  TNF  Hs00174128_m1;  Human
MUC4:  TaqMan  probe  MUC4  Hs00366414_m1;  Human
DEFB4:  TaqMan  probe  DEFB4  Hs  00175474_m1;  and
Human  GAPDH  as  the  calibrator  gene:  Taqman  probe
GAPDH Hs99999905_m1). The PCR conditions were 95 °C
for 10 min (AmpliTaq Gold DNA Polymerase Activation)
followed by 40 amplification cycles (95 °C for 15 s then 60 °C
for 1 min).
The  Relative  Quantification  (RQ)  minimum  and  RQ
maximum  define  statistical  boundaries  for  relative
quantification,  based  on  a  95%-specified  RQ  Min/Max
confidence setting. A confidence setting of 95% means that
the user can expect the true RQ value to fall within the RQ
Min/Max range with a 95% confidence. The RQ Min/Max is







where  ΔΔCT(s,t)=ΔCT(s,t)  -  ΔCT(calibrator,t);  s=sample  name;
t=target  detector;  T=student’s  T  value  at  the  selected
confidence setting using a degree of freedom that is associated
with  the  test  sample  ΔCT(s,t);  and  VAB  is  the  Applied
Biosystems’ variability function for calculating the variability
of the test sample ΔCT statistic.
Calculations  of  relative  gene  expression  used  relative
differences in the threshold cycle CT (the PCR cycle at which
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115the fluorescence reaches a given value or threshold that is in
the log-linear range of amplification). Samples containing
higher levels of expression of a particular gene reach the
threshold  value  at  lower  cycle  numbers  during  PCR  than
samples containing lower levels of expression of the same
gene. Because each cycle in the PCR reaction corresponds to
a twofold increase in PCR product, a difference of one in
threshold cycle number represents a twofold difference in the
expression  of  a  particular  gene  or  internal  control  target
sequence  and  can  be  considered  as  significant.  Duplicate
cultures  were  analyzed  and  the  data  were  represented  as
Relative Quantification data (RQ) ± standard deviation. The
PCR instrument’s integrated software set a confidence level
of 95% (i.e., for a true range of biologic significance).
PART 2: Products, controls and treatments: In the second part
of the study a serie of commercially available tear substitutes,
were tested by Real Time PCR for their efficacy and capability
to prevent desiccation of HCE tissue in our EDEV model.
Scanning  electron  microscopy  (SEM)  and  histological
analysis were performed at selected treatments time points.
The following treatments (all routinely used for the long-
term treatment of dry eye symptoms) were tested: sodium
hyaluronate  0.2%  (Hyalistil®;  SIFI,  Catania,  Italy);  TS-
Polysaccharide (TSP 0.5%®); sodium hyaluronate 0.2% and
TS-Polysaccharide 0.2% (Xiloial®; Farmigea, Pisa Italy) ;
and carbossimethylcellulose (Optive®; Allergan, Irvine, CA).
A  dexamethasone  preparation  0.15%  (Etacortilen®;  SIFI,
Catania, Italy) was also assessed. According to the chemical
and  physical  preservative  systems  (Table  1),  a  different
cytotoxicity  should  be  expected.  The  products  have  been
previously  tested  for  their  compatibility  and  for  24  h
application any cytotoxic effect has been quantified (data not
shown).
Tear substitutes were applied via two different protocols
(Figure 1). In the first procedure (treatment during EDEV
induction), 50 μl of test product was directly applied and
gently spread over the whole epithelium surface at the same
time  as  induction  of  dry  eye  conditions.  Tissues  were
maintained for 24 h and 48 h to determine the efficacy of the
test products in counteracting the establishment of EDEV. In
the second procedure (post-treatment on established EDEV),
50  μl  of  test  product  was  applied  to  tissues  previously
maintained for 24 h under EDEV conditions; tissues were then
followed for further 24 h to determine the ability of the test
product to restore the normal eye condition. As a negative
control,  HCE  were  maintained  under  standard  conditions
(90% humidity, 37 °C and 5% CO2) and treated with saline
solution for its neutral effect on the epithelium surface; these
tissues are coded as CONTROL-HCE. Finally, untreated HCE
tissues maintained in the controlled EDEV setting (<40%
humidity, 40 °C, and 5% CO2) were used as a positive control
(EDEV-HCE).
Statistical analysis: Statistical comparisons of controls with




Cell  viability—The  viability  of  HCE  tissue  was
evaluated by AlamarBlue (AB) at 24, 48, and 72 h after dry
eye induction and compared with control HCE. The test has
been performed on duplicate cultures. As shown in Figure 2,
after the maximum exposure time (72 h), the survival of HCE
in  EDEV  conditions  was  still  quite  good  (70%  cellular
viability)  compared  with  the  CONTROL-HCE  (cellular
viability 100%).
mRNA quantification of MMP9, MUC4, DEFB4, and
TNF-α—Duplicate cultures for the gene expression study
have  been  used.  The  transcriptional  study  by  qRT–PCR
revealed that expression of the inflammatory cytokine TNF-
α was increased at 24 h following the induction of EDEV
conditions.  TNF-α  expression  was  maximal  at  48  h  and
remained  significantly  higher  than  levels  in  untreated
CONTROL-HCE  tissues  until  72  h  post-EDEV  induction
(Figure 3A). Overexpression of MMP9 was observed at 24 h
and 72 h following EDEV induction (Figure 3B). Consistently
high levels of MUC4 expression were observed in EDEV-
HCE  tissues  at  all  time  points  analyzed  (Figure  3C).  A
moderate increase in the expression of DEFB2 in EDEV-HCE
was observed at 24 h and 72 h after dry eye induction (Figure
3D).
The overexpression of MMP9 and MUC4 was expected
under EDEV conditions. Previous studies have shown that
MMP-9  correlates  with  increased  degeneration  of  the
extracellular  matrix  due  to  inflammation  and  tissue
sufferance. Upregulation of MUC4 occurs as an epithelial
TABLE 1. IDENTIFICATION OF COMMERCIALLY AVAILABLE TEAR SUBSTITUTES.
Identification code Active ingredient Preservation system
Etacortilen® DEXAMETHASONE 0.15% UNPRESERVED
Hyalistil® SODIUM HYALURONATE 0.2% THIOMERSAL
Xiloial® SODIUM HYALURONATE 0.2% TS-Polisaccaride 0.2% UNPRESERVED
TSP 0,5%® TS-Polisaccaride 0,5% UNPRESERVED
Optive® CARBOSSIMETHYLCELLULOSE 0.5% Glycerin 0.9% PURITE®
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116defense mechanism in response to loss of tissue integrity and
microvilli disappearance [24].
Histological  analysis—Figure  4  shows  the  overall
morphology viewed under a light microscope of CONTROL-
HCE and EDEV-HCE tissue at 24 h, 48 h, and 72 h. The
resolution of the pictures is the maximum allowed to see the
morphology  of  cells:  in  case  of  reduced  hydration  the
resolution of the images is less clear. CONTROL-HCE tissue
morphology was perfectly preserved at all three time points
studied (Figure 4A-C): a flattened layer of non keratinized
superficial  cells,  an  intermediate  cell  layer  (with  cells
displaying lateral cytoplasmic extensions similar to the wing
cells), and the basal layer of regular column cuboidal cells
were all clearly visible. A small and normal increase in tissue
thickness was observed over time.
A dramatic reduction in the thickness of the epithelium
was observed in EDEV-HCE compared to CONTROL-HCE
tissue  (Figure  4D-F).  It  is  important  to  highlight  that  the
epithelium  in  EDEV-HCE  was  viable,  as  assessed  by
AlamarBlue at 24 h (100% viability), 48 h (80% viability),
and 72 h (70% viability). The reduction in thickness appears
to be related to loss of water due to the severe dry experimental
conditions. Therefore, we concluded that low humidity and
high temperature appear to reproduce the dry environmental
conditions that cause ocular discomfort and inflammation.
Immunofluorescence analysis for MMP9 and MUC4
—Immunofluorescence  analysis  of  EDEV-HCE  at  24  h
following induction of EDEV under controlled conditions
showed diffuse but weak MMP9 staining (green) in almost all
layers of the epithelium (red nuclei stained with propidium
iodide)  that  was  absent  in  CONTROL-HCE  tissue.  The
Figure 1. Schematic representation of
protocol  of  EDEV  induction  and
products  treatment.  EDEV:
Experimentally induced in vitro dry eye.
Figure 2. Reduction of AlamarBlue (%)
resulting in % viability in EDEV-HCE
compared to the CONTROL-HCE at 24
h,  48  h,  and  72  h.  The  vertical  lines
represent  the  standard  deviation  (SD)
between  two  different  tissues.  HCE:
human corneal epithelium.
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117MMP9 signal was increased at 48 h and 72 h after induction
of  dry  eye  condition.  At  24  h,  MUC4  was  expressed
constitutively  in  CONTROL-HCE  in  almost  all  cellular
layers, and strong MUC4 staining was observed in EDEV-
HCE (Figure 5). At 48 h and 72 h, the protein revealed in
EDEV-HCE  a  preferential  apical  localization.  The
CONTROL-HCE  tissues  in  Figure  5A  and  5E  showed
respectively  MMP9  and  MUC4  expression  after  24h.
CONTROL-HCE at 48h and 72h were not illustrated because
any difference from 24h control has been noted.
Microvilli analysis by scanning electron microscopy
—SEM analysis revealed that CONTROL-HCE tissue was
rich in microvilli and surprisingly close to the human model.
Figure  6A,B  show  the  epithelium  surface  at  different
Figure 3. Set-up of EDEV model. Real-
time PCR analysis showing the relative
changes  of  TNF-α  (A),  MMP9  (B),
MUC4  (C),  and  DEFB2  (D)  mRNA
Control  and  EDEV  HCE.  Values  are
means±  SD  of  two  different  HCE
tissues.
Figure 4. Histomorphological analysis
of 3D-HCE after 24 h, 48 h, and 72 h
cultivated in control condition (A, B,
C) and in controlled EDEV condition
(D, E, F). Magnification 20×.
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118magnifications. A progressive reduction in the number of
microvilli was observed following induction of EDEV (Figure
6C-H). At 24 h post-induction, the number of microvilli was
reduced (Figure 6C,D); microvilli were no longer present at
Figure 5. Immunofluorescence staining of MMP9 (A, B, C, D) and MUC4 (E, F, G, H) in control and EDEV HCE at 24 h, 48 h, and 72 h.
MMP9 and MUC4 are stained in green and red nuclei are stained with propidium iodide.
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119Figure 6. SEM images of human corneal microvilli and mucin network and in standard and EDEV HCE. Scanning electron microscopy
showing HCE epithelium in control HCE condition (A, B at 20 and 5 μm of magnification) and in EDEV setting at 24 h (C, D), 48 h (E, F),
and 72 h (G, H). The microvilli in C-H are identified at a different magnification (2–5 μm). The in vivo impression cytology with SEM on
humans is illustrated in the box on the top of the Figure (microvilli on the left and mucin network on the right). The reproduction of the images
are authorized by Professor Del Prete (University of Napoli).
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12048 h and 72 h, and the desiccating stress was apparent on the
epithelium surface. In the EDEV condition the tissue integrity
was no longer observed (Figure 6E-H). Every time point was
shown at two different magnification (2 and 5μm) to better
discriminate the morphology of the cells.
Considering the results of PART I for all the parameter
tested and our encouraging gene transcription results in line
with  clinical  findings  showing  increased  expression  of
MMP9, TNF-α, MUC4, and DEFB2 [18,19,22], the EDEV-
HCE model was subsequently used to assess the efficacy of
tear substitutes.
PART 2:
Efficacy  of  tear  substitutes  in  counteracting  or
repairing  dryness  in  the  EDEV-HCE  model—As  the
experimentally established EDEV model could successfully
mimic the features of a dry ocular surface within 24 h of EDEV
induction (shown in PART 1), we tested the effects of various
commercially available artificial tears with proven efficacy
for the induced dry eye condition.
Application  of  tear  substitutes  during  EDEV
induction—All  tear  substitutes  had  a  significant  stronger
effect  on  TNF-α  mRNA  increase  after  48  h  of  treatment
compared to 24 h. After 24 h of treatment, all of the tear
substitutes  tested  induced  an  overexpression  of  TNF-α.
Etacortilen®, a well known anti-inflammatory drug, was the
only agent able to control and block the expression of the
inflammatory genes to the same RQ values as those observed
in the EDEV-HCE (Figure 7A). The upregulation of MMP9
observed  at  24  h  in  the  EDEV  model  was  controlled  by
treatment with all tear substitutes except for Xiloial® and
Optive®. At 48 h all the tears except Hyalistil® were able to
counteract the increased expression of MMP9 (Figure 7B).
Higher levels of MUC4 mRNA were observed after 24 h
of Xiloial® treatment compared to the other tear substitutes
and EDEV-HCE (Figure 7C). However all products except
Optive® after 24 h and 48 h induced a significant upregulation
of MUC4 expression compared to EDEV-HCE. Membrane-
associated mucins have a role as a protective barrier gene.
Increased expression of MUC-4 is associated to a positive
adaptive mechanism to counteract the atrophy and the loss of
lipidic film.
No significant differences were found in the expression
of DEFB2 compared to EDEV-HCE after 24 h of treatment
with Hyalistil®, Etacortilen®, and Xiloial®. TSP 0.5%® and
Optive® restored the Control HCE value of DEFB2 (Figure
7D). After 48 h, all of the tear substitutes had counteracted the
increase  in  DEFB2  expression  observed  in  EDEV-HCE
(Figure 7D).
Application of tear substitutes on established EDEV-
HCE—As shown in Figure 1, tear substitutes were applied to
tissues  previously  maintained  for  24  h  under  EDEV
conditions;  established  EDEV-HCE  tissues  were  then
followed for further 24 h to assess polymers activity on the
expression of the selected biomarkers and on the microvilli
structure.
In the established EDEV-HCE model, TNF-α expression
was upregulated following treatment with Optive®, Xiloial®,
and Hyalistil®. On the contrary Etacortilen® and TSP 0.5%®
did not induce an increase of  TNF-α, suggesting an anti-
inflammatory  efficacy  (Figure  8A).  All  of  the  products
applied showed efficacy in controlling MMP9 expression. A
decrease of MMP9 expression in comparison to EDEV alone
was  observed  (Figure  8B).  All  tear  substitutes  increased
MUC4 mRNA expression relative to EDEV-HCE (Figure
8C). A significant decrease in DEFB2 expression was also
observed following treatment with all the tears substitutes
compared to EDEV-HCE (Figure 8D).
Figure 7. Results of EDEV biomarkers
gene expression study. Real-time PCR
analysis showing the relative changes of
TNF-α (A), MMP9 (B), MUC4 (C), and
DEFB2 (D) mRNA after 24 h and 48 h
treatment with different tear substitutes
simultaneously the induction of EDEV.
A  twofold  change  of  Relative
Quantification  (RQ)  is  usually
considered significant in comparison to
the calibrator (CONTROL-HCE at each
time point). A two-tailed Student’s t-test
was  used  to  determine  statistical
significance  for  real-time  PCR.  Data
were considered significant at p<0.05
(*), p<0.01 (**), and p<0.001 (***).
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121Histologic  analysis  at  24  h—Figure  9  shows  the
morphology  of  HCE  after  treatment  with  various  tear
substitutes. Epithelial thickness was reduced in EDEV-HCE
compared to CONTROL-HCE at 24 h (Figure 9A). After 24 h
simultaneous  treatment  with  EDEV  induction,  Hyalistil®,
Xiloial®, and TSP 0.5% restored the initial morphology of
HCE,  which  resembled  the  standard  conditions  (Figure
9C,E,F). Etacortilen® and Optive® induced epithelial damage;
the integrity of the epithelium was partially lost (Figure 9D-
G).
SEM analysis at 24 h—SEM images showing the overall
morphology after treatment of HCE are shown in Figure 10.
In EDEV-HCE after 24 h, the microvilli almost completely
disappeared with the breakdown of epithelial cells (Figure
10B). Partial restoration of microvilli density was observed
with some of the products (Figure 10C-G) compared to the
CONTROL-HCE (Figure 10A); in particular, the morphology
of microvillial cells conserved for TSP 0.5%®, Xiloial® and
Hyalistil®.
DISCUSSION
The present study investigated the biologic response to dry
environmental cultivation conditions in a 3D model of HCE
by monitoring the kinetics of a biologically relevant gene
signature over a 72 h time period. By using this dynamic
approach it was possible to define the optimal duration of the
dryness conditions to assess the activity of different polymers
contained  in  topically-applied  tear  substitutes.  This  new
EDEV model was induced by exposure of HCE to a low-
humidity environment (<40%) and increased temperature (up
to 40 °C). We showed that the time necessary to induce this
experimental model and to mimic the characteristic features
of the corneal epithelium in the DTS was 24 h; during this
time  cell  viability  was  not  affected  as  quantified  by
AlamarBlue Assay. The transcriptional study has shown the
relevance of selected biomarkers and the tissue response to
EDEV setting and product treatment confirmes the role of
each gene as described in the literature.
Figure 8. Results of EDEV biomarkers
gene expression study. Real-time PCR
analysis showing the relative changes of
TNF-α (A), MMP9 (B), MUC4 (C), and
DEFB2 (D) mRNA after 24 h treatment
on established EDEV model. A twofold
change of Relative Quantification (RQ)
is  usually  considered  significant  in
comparison  to  the  calibrator
(CONTROL-HCE at each time point).
A two-tailed Student’s t-test was used to
determine  statistical  significance  for
real-time PCR. All the data presented in
this graphic were significant at p<0.001.
Figure  9.  Histological  analysis.  A:
Normal  morphology  of  control  HCE
with  saline  solution.  B:  Epithelial
thickness  reduced  in  EDEV-HCE.  C:
Hyalistil®; D: Etacortilen®; E: Xiloial®;
F:  TSP  0,5%®;  G:  Optive®.
Magnification 20×.
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122Figure 10. Images of microvilli in in vitro reconstituted corneal epithelium. Scanning electron microscope images showing Control (A) and
EDEV-HCE tissue induced for 24 h (B) with treatments with different tear substitutes (C-Hyalistil®; D-Etacortilen®; E-Xiloial®; F-TSP
0,5%®; G-Optive®). Two μm magnification.
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123The EDEV-HCE model is characterized by increase in
MUC4, MMP9, TNF-α, and DEFB2 expression.
Transcription studies on the gene signature for epithelial
dryness  confirmed  previous  clinical  findings  showing
alterations in the carbohydrate component of mucins in dry
eye, resulting in abrasive stress and epithelial damage [25].
MMP9 was increased in the tear fluid of patients with dry eye
[17]  and  increased  production  and  activation  of  pro-
inflammatory  cytokines  (TNF-α  and  IL1-α)  have  been
observed at the stressed ocular surface in dry eye [18,19].
Furthermore DEFB2 levels were increased in subjects with
dry eye showing signs of ocular irritation [26].
The  EDEV-HCE  model  stimulated  the  production  of
inflammatory factors (TNF-α and MMP-9). Higher levels of
TNF-α were found at all time points studied (24 h, 48 h, and
72 h) compared with CONTROL-HCE tissue. These data are
in line with the results described in other studies, which found
increased concentrations of pro-inflammatory cytokines and
chemokines (such as IL-6, IL-1, TNF-α) in the tear fluid
[18,19]. In dry eye, increased production and activation of
pro-inflammatory cytokines (interleukin IL-1 and TNF-α) and
proteolytic enzymes produced by stressed ocular surface and
glandular epithelial cells, as well the inflammatory cells that
infiltrate these tissues, have been reported.
Increased levels of MMP9 were also present in EDEV-
HCE at 24 h and 72 h following EDEV induction. Increased
levels of proinflammatory cytokines and metalloproteinases
have been observed on the ocular surface of patients with KCS
[27]. Increased concentration and activity of MMPs in the tear
fluid of patients with dry eye have previously been reported
[17].  Furthermore,  increased  levels  of  TNF-α  and  MMP9
mRNA were shown with real-time and gene array data in an
induced dry eye model in the mouse [6]. TNF-α and IL-1 also
stimulate  the  production  of  MMPs  by  epithelial  and
inflammatory  cells  [28].  MMP9  is  the  most  important
gelatinase present on the ocular surface and MMP9 levels
appear to be higher in the tear fluids of patients with KCS and
in particular in patients with ulceration. MMP-9 lyses a variety
of different substrates including components of the corneal
epithelial  basement  membrane  and  tight  junction  proteins
(such  as  zonula  occludens-1  [ZO-1]  and  occludin),
compromising the integrity of the corneal epithelial barrier.
Proteolitic cleveage of occludin accelerates loss of superficial
corneal  epithelium,  thus  increasing  the  permeability  of
corneal  epithelium.  An  MMP9  knockout  mouse  model
confirmed  that  increased  MMP9  activity  in  response  to
experimental dry eye disrupts the corneal epithelial barrier
[29]. MMP-9 appears to play a physiologic role in regulating
corneal  epithelial  desquamation.  The  increased  MMP-9
activity in KCS may be responsible in part for the deranged
corneal epithelial barrier function, increased corneal epithelial
desquamation, and corneal surface irregularity.
A  twofold  induction  of  MUC4  mRNA  occurred  in
EDEV-HCE.  MUC4  is  a  membrane-bound  mucin  and  is
secreted by conjunctival and corneal epithelial cells [30,31].
MUC4  upregulation  found  in  EDEV-HCE  model  can  be
interpreted as an early marker that acts as a positive signal to
stimulate the production of mucin in a situation in which
mucin protein is lacking. Three types of mucins are present at
the  ocular  surface.  The  large  gel-forming  mucin-5  AC
(MUC5AC) is expressed by conjunctival goblet cells. Some
cells of the lacrimal gland acini express the small soluble
mucin MUC7. The corneal and conjunctival epithelia express
the membrane-associated mucins (MUCs 1, 4, and 16) [4].
These mucins are mainly concentrated on the tips of the apical
cells’  microplicae,  forming  a  dense  glycocalyx  at  the
epithelial-tear  film  interface.  However,  they  can  also  be
released from the cell surface and are found in the tear film
[20]. Traditionally, mucin function at the ocular surface has
been  ascribed  to  secreted  gel-forming  mucins  acting  as
lubricating  agents  and  clearing  molecules.  New  evidence
shows a role for cell surface-associated mucins in providing
barrier function to corneal and conjunctival epithelia.
Cell surface-associated mucins form a thick cell surface
glycocalyx that may extend up to 500 nm from the plasma
membrane  at  the  ocular  surface.  Cell  surface-associated
mucins provide dishadesive properties, boundary lubrication
and prevent adhesion of facing cell surfaces (i.e., corneal
epithelium and tarsal conjunctiva) during blinking or sleeping
[25]. These mucins can contribute to the maintenance of the
mucosal  barrier  integrity,  preventing  the  penetration  of
extracellular  molecules  on  ocular  surface  epithelia  and
maintaining epithelial protection, and therefore a healthy wet-
surface phenotype. Recent studies on cell surface-associated
mucins  have  shown  that  their  carbohydrate  component  is
altered  in  dry  eye  syndrome.  Alteration  of  mucin  O-
glycosylation  in  dry  eye  compromises  the  ocular  surface
epithelial barrier and results in increased abrasive stress and
epithelial damage. Ocular mucus protects against bacterial
adherence to the corneal epithelium and alteration in mucus
production promote bacterial adherence to the cornea [32].
The ocular surface in dry eye disease is compromised and
therefore at risk for microbial infections. Subjects with dry
eye may have an alternative mechanism to protect the ocular
surface  from  infection.  One  possibility  is  that  naturally
occurring antimicrobial peptides, such as human β-defensins
(hBDs),  provide  alternate  means  of  defense  for  the
compromised ocular surface in dry eye, thus reducing the risk
of corneal and conjunctival infections [22]. Defensins are
antimicrobial peptides that are involved in innate host defense.
β-defensins are secreted by epithelial cells and are active in
vitro against several different bacteria, fungi and enveloped
viruses  and  are  thought  to  perform  their  microbicidal
functions  by  forming  pores  in  microbial  cell  membranes.
Although hBDs are primarily antimicrobial in nature, they can
influence cellular activities such as proliferation, cytokine
production, and histamine release by mast cells. Defensins
also have chemotactic effects on mast cells, T-cells, dendritic
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124cells, and monocytes and promote dendritic cell maturation.
At least some of these functions appear to be mediated by
receptors  such  as  toll-like  receptor-4,  and  CC-chemokine
receptor-6. These other activities have led to the suggestion
that  defensins  are  a  link  between  innate  and  adaptive
immunity. It is possible that expression of hBD-2 plays a
chemotactic  role  in  mediating  the  increase  in  T-cell
subpopulations observed in subjects with non-Sjögren’s dry
eye.  Further,  hBD-2  stimulated  histamine  release  by
conjunctival mast cells may elicit signs and symptoms of
ocular irritation. Therefore, while an increased expression of
hBD-2 may be beneficial in terms of antimicrobial protection,
it may also contribute to ocular surface damage observed in
subjects  with  dry  eye.  The  observed  low  but  significant
upregulation of beta-defensin 2 in the EDEV-HCE seems to
be rather a defense mechanism consequent to the damage
observed  than  an  active  mechanism  of  antimicrobial
protection.
A  gradual  breakdown  and  disruption  of  epithelial
integrity following EDEV induction was observed in our SEM
experiments  over  the  72  h  period.  However,  EDEV-HCE
tissue viability and morphology was fairly well preserved, as
indicated  by  the  viability  assay  and  histomorphologic
analysis, which showed a reduction in EDEV-HCE tissue
thickness.
Our results suggest that this new experimentally induced
EDEV-HCE model can been used to test the efficacy of a
series  of  polymers  in  commercially  artificial  tears  in
preventing  or  reducing  the  molecular  and  structural
modifications characteristic of the DTS at corneal epithelium
level. Dry eye symptoms are commonly treated with these eye
drops; formulations are designed to interact with the mucus
and  aqueous  layers  of  the  tear  film,  and  thanks  to  their
composition replacing lost moisture and stabilizing the tear
film.
The  application  of  tears  substitutes  during  EDEV
induction allowed products discrimination for their efficacy
in promoting the increase of MUC4 (Etacortilen®, Hyalistil®,
Xiloial®, and TSP 0,5%®), associated to a positive adaptive
and defense mechanism to fight the atrophy and the loss of
lipidic  film.  Products  were  also  discriminated  for  their
efficacy in decreasing TNF-α (Etacortilen®) correlated to an
antiinflammatory mechanism, in limiting the overexpression
of MMP9 (Etacortilen®, Hyalistil®, and TSP 0,5%® at 24 h and
Etacortilen®,  TSP  0,5%®,  and  Xiloial®  at  48  h)  and  in
regulating the DEFB2 restoring the control HCE value (TSP
0,5%®at 24 h) and counteracting the increasing DEFB2 gene
((Etacortilen®,  Hyalistil®,  TSP  0,5%®,  Xiloial®,  and
Optive®at 48 h) correlated to an anti-microbial effect on the
ocular surface and protection from ocular damage.
In the post EDEV treatment, the efficacy in restoring the
control HCE homeostasis has been quantified for the ability
in increasing MUC4 (Etacortilen®, Hyalistil®, TSP 0,5%®,
Xiloial®, and Optive®), in contrasting the increase of TNF-α
(Etacortilen®  and  TSP  0,5%®),  in  decreasing  MMP9  and
DEFB2 (Etacortilen®, Hyalistil®, TSP 0,5%®, Xiloial®, and
Optive®).
This study has demonstrated that our EDEV-HCE model
reproduce the morphological and molecular modifications to
the corneal epithelium in the DTS suitable to test products
activity in preclinical trials in both counteracting the induction
of  dryness  conditions  or  restoring  the  homeostasis  in  an
established EDEV-HCE model.
By using a dynamic approach, we were able to define a
gene signature of DTS that could be predictive of corneal
damage in vivo. The transcriptomic approach applied to 3D
human  tissues  appears  to  be  an  encouraging  method  for
gaining  a  deeper  understanding  of  the  DTS  on  corneal
epithelium and for studying the epithelial response with non-
invasive  techniques.  By  using  this  new  experimentally-
induced EDEV model, it was possible to discriminate between
different  artificial  tear  products  (with  respect  to  the
mechanism  of  action  of  polymers  and  others  ingredients)
suggesting  that  this  may  represent  a  promising  tool  for
preclinical screening or for research studies on the molecular
underlying mechanisms of the DTS.
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